Navigation Links
Pharmaceutical Industry Insiders, VIPs All Coming Together for Future of Pharma Market, Pharmaceutical Competitive Intelligence
Date:9/8/2010

PARSIPPANY, N.J., Sept. 8 /PRNewswire/ -- Today every major pharmaceutical industry executive searches for ways to succeed when looking toward the future of pharma.  In an unprecedented move, they're all coming together in just a few weeks.  All the big names in pharma.  All in one place.  That's the scene you'll find on September 21-22, 2010 at the Pharma CI Conference & Exhibition at the Hilton Parsippany Hotel in Parsippany, New Jersey, USA.  In fact, more than 250 pharma thought leaders have already signed up.  And with each day, more people say they want to be part of this historic, high quality event.  To see who's coming so far, go to www.Pharmaciconference.com/attendees.html.

This comprehensive conference is geared toward anyone who has a stake in the pharmaceutical marketplace.  It's truly an eye-opening experience for anyone interested in what happens next for pharma giants, as well as up-and-comers.

Pharmaceutical decision makers say they want the most accurate and up-to-date information about the pharma industry, especially pharmaceutical competitive intelligence.  It's the kind of data only true experts can provide.  And these experts are all coming to the Pharma CI Conference & Exhibition.   More than 75 preeminent speakers will delve into current and future hot topics.  To see the speaker list, go to www.Pharmaciconference.com/speakers.html.

The Pharma CI Conference is the industry's gold standard for senior level pharma, biotech, and medical device professionals seeking the latest in competitive intelligence and business intelligence.  

Highlights:

  • Unparalleled Networking: Meet hundreds of peers in just two days.
  • Superior Speakers: 75+ senior level speakers with depth of knowledge found nowhere else.  
  • Expansive Coverage: 50+ sessions (presentations, panel and roundtable discussions, and workshops) cover every important topic.

2010 sponsors/exhibitors include:

Fletcher/CSI, Deallus, Fuld & Company, Applied Intelligence, Aurora WDC, BCC Research, Best Practices, BioMedTracker, Brady Corp, Capital IQ, CBR Pharma Insights, Digimind, Dow Jones, dtw, Dunn Group, EvaluatePharma, Evalueserve, Financial Times, FirstWord, Indegene, Larvol Group, Lifescience Dynamics, MedPredict, Murray Hill Center, Northern Light, PharmaForce, PharmaVoxx, Prescient Life Sciences, Proactive Worldwide, research reporter, SAI MedPartners, Search Technology, Sedulo Group, ValueCentric, and Wolters Kluwer Pharma Solutions.  

For more information or registration, go to www.Pharmaciconference.com, call 212.228.7974/713.398.6888 or email info@pharmaciconference.com.


'/>"/>
SOURCE Pharma CI Conference
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2017)... 11, 2017  Thornhill Research Inc. ( ... an $8,049,024 USD five-year, firm-fixed-priced, indefinite-quantity/indefinite-delivery contract by ... Commercial Corporation (CCC) ( Ottawa, Ontario, Canada ... administer general anesthesia to patients requiring emergency medical ... US Marine Corps have been a longtime partner ...
(Date:5/10/2017)... 10, 2017 Global Health Intelligence (GHI), ... America , published its 2017 ranking of the ... on extensive data analysis from GHI,s hospitals database for ... for the region. The GHI database covers 86% of the ... than 130 data points for each institution in key areas ...
(Date:5/10/2017)... May 10, 2017 Radiology has become the ... costs have also spiraled to the number one ranking ... radiology than ever before as the most complete and ... patient with lower back pain an MRI may confirm ... for pain, resulting in entirely different treatment protocols.  In ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... 26, 2017 , ... Boar’s Head Brand®, one of the ... Day entertaining that are sure to satisfy your guests’ flavor cravings, while adding ... cheeses featured in these refreshingly balanced recipes are packed with flavor, creating the ...
(Date:5/26/2017)... ... May 26, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... is focusing on the Peace Agreements being discussed by President Donald Trump and the ... race to try to speed up peace talks in the continuous battle between Israel ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: ... the creation of published author Laura Weigel Douglas, an avid reader who lives in ... house that sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... “Cactus Jack: ... had on so many others. “Cactus Jack: Against All Odds” is the creation ... Walter D. Hubbard is married to Jack Carlisle’s third child Jane. Walter. ...
(Date:5/24/2017)... ... 2017 , ... Dr. Alan I. Benvenisty, MD is dual board certified in ... known for his distinguished expertise and experience in the diagnosis and treatment of vascular ... treating renovascular disease and aortic aneurysm . He is known for his minimally ...
Breaking Medicine News(10 mins):